Jean Jacques Bienaime - 13 Dec 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role: Chief Executive Officer, Director
Signature: /s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol: BMRN
Transactions as of: 13 Dec 2022
Net transactions value: -$106,890
Form type: 4
Filing time: 15 Dec 2022, 15:43:26 UTC
Previous filing: 06 Dec 2022
Next filing: 13 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BMRN	Common Stock	Sale	$106,890	-1,000	-0.31%	$106.89	320,424	13 Dec 2022	Direct	F1
holding	BMRN	Common Stock						247,533	13 Dec 2022	Shares held by Jean-Jacques Bienaime Family Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 100 shares, with the reporting person's purchase of shares at a price of $86.1178 on November 2, 2022. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.

Content

The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 100 shares, with the reporting person's purchase of shares at a price of $86.1178 on November 2, 2022. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.